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Gunjan D Hariani1, Ernest T Lam3, Tammy Havener4, Pui-Yan Kwok3, Howard L McLeod4,5, Michael J Wagner4 and
Alison A Motsinger-Reif1,2*Correction
After publication of this work [1], it has come to our at-
tention that there is an error in the author list of the ini-
tial version of this manuscript; rather than Ernest J Lam,
the second author of the manuscript should be listed as
Ernest T Lam.
We publish this correction to update the author list
with this information. The correct author list is as
follows:
Gunjan D Hariani, Ernest T Lam, Tammy Havener,
Pui-Yan Kwok, Howard L McLeod, Michael J Wagner
and Alison A Motsinger-Reif
This error was introduced during the final production
process and the editors of BMC Research Notes apolo-
gise for any inconvenience caused.
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